Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
7
Number of overlapping holdings
18.9%
% of ARKG's 39 holdings also in XDNA
30.4%
% of XDNA's 23 holdings also in ARKG
Overlap by Weight
Sector Drift (ARKG minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in ARKG |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 7.3% | 15.1% | 7.3% |
|
INTELLIA THERAPEUTICS, INC. | 4.0% | 8.7% | 4.0% |
|
BEAM THERAPEUTICS, INC. | 3.9% | 13.7% | 3.9% |
|
VERVE THERAPEUTICS, INC. | 1.5% | 4.5% | 1.5% |
|
VERTEX PHARMACEUTICALS INC | 2.7% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
ARKG Overweight Relative to XDNA
|
TWIST BIOSCIENCE CORP. | 6.1% |
|
EXACT SCIENCES CORP | 5.4% |
|
RECURSION PHARMACEUTICALS, INC CLASS | 5.2% |
|
SCHRODINGER, INC. | 4.7% |
|
IONIS PHARMACEUTICALS, INC. | 4.3% |
|
ACCOLADE, INC. | 4.0% |
|
CAREDX, INC. | 3.7% |
|
10X GENOMICS INC CLASS A | 3.6% |
 |
ALCOBRA LTD | 3.5% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | 3.5% |
ARKG Underweight Relative to XDNA
|
BEAM THERAPEUTICS, INC. | -9.7% |
|
THERMO FISHER SCIENTIFIC INC | -9.5% |
|
CRISPR THERAPEUTICS AG | -7.8% |
|
EDITAS MEDICINE, INC. | -5.7% |
|
PRIME MEDICINE, INC. | -4.8% |
|
INTELLIA THERAPEUTICS, INC. | -4.7% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
|
ABBVIE INC | -3.8% |
|
ALLOGENE THERAPEUTICS, INC. | -3.4% |